Company Information

Company Ioulia & Irene Tsetis Pharmaceutical Laboratories (INTERMED) S.A.
Pharmaceuticals & Biotechnology
Privately Held
Global Compact Status:
Participant Since
07 October 2016
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2024

Communication On Progress

Published On Title Level/Status
28-Mar-2024 2023 Communication on Progress Submitted
22-Jun-2022 Reporting Cycle Adjustment Not applicable
24-Jun-2021 Communication on Progress 2021 Active
19-Sep-2019 Communication on Progress 2019 Active
27-Sep-2018 Communication on Progress 2018 Active
28-Sep-2017 Communication on Progress 2017 Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.